Rifaximin's Effect on Covert Hepatic Encephalopathy in Cirrhosis Patients With Small Intestinal Bacterial Overgrowth and Gastrointestinal Dysmotility

Conditions:   Cirrhosis, Liver;   Minimal Hepatic Encephalopathy;   Small Intestinal Bacterial Overgrowth;   Gastrointestinal Motility Disorder Intervention:   Drug: Rifaximin Sponsor:   Ronnie Fass, MD Not yet recruiting

Source: ClinicalTrials.gov - January 28, 2020 Category: Research Source Type: clinical trials